HIGHLIGHTS
- who: Rita Mencucci and colleagues from the Department of Neurosciences, Psychology, Pharmacology and Child Health, Eye Clinic, University of Health (DiNOGMI), Universitu00e0 di Genova, Genova, Italy have published the Article: Corneal Findings Associated to Belantamab-Mafodotin (Belamaf) Use in a Series of Patients Examined Longitudinally by Means of Advanced Corneal Imaging, in the Journal: (JOURNAL)
SUMMARY
Ocular surface diseases are common among hematological patients, either due to the underlying diseases or the therapies employed for their treatment. The authors present a series of patients who developed corneal adverse events associated with belamaf use . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.